193 related articles for article (PubMed ID: 30914429)
1. Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells.
Revach OY; Sandler O; Samuels Y; Geiger B
Cancer Res; 2019 May; 79(10):2634-2648. PubMed ID: 30914429
[TBL] [Abstract][Full Text] [Related]
2. Mechanical interplay between invadopodia and the nucleus in cultured cancer cells.
Revach OY; Weiner A; Rechav K; Sabanay I; Livne A; Geiger B
Sci Rep; 2015 Mar; 5():9466. PubMed ID: 25820462
[TBL] [Abstract][Full Text] [Related]
3. AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.
de Polo A; Luo Z; Gerarduzzi C; Chen X; Little JB; Yuan ZM
J Mol Cell Biol; 2017 Apr; 9(2):154-165. PubMed ID: 27927748
[TBL] [Abstract][Full Text] [Related]
4. PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells.
Nicholas NS; Pipili A; Lesjak MS; Ameer-Beg SM; Geh JL; Healy C; MacKenzie Ross AD; Parsons M; Nestle FO; Lacy KE; Wells CM
Oncotarget; 2016 Oct; 7(43):70881-70897. PubMed ID: 27765920
[TBL] [Abstract][Full Text] [Related]
5. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
6. MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.
Tworkoski KA; Platt JT; Bacchiocchi A; Bosenberg M; Boggon TJ; Stern DF
Pigment Cell Melanoma Res; 2013 Jul; 26(4):527-41. PubMed ID: 23617806
[TBL] [Abstract][Full Text] [Related]
7. Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.
Sensi M; Catani M; Castellano G; Nicolini G; Alciato F; Tragni G; De Santis G; Bersani I; Avanzi G; Tomassetti A; Canevari S; Anichini A
J Invest Dermatol; 2011 Dec; 131(12):2448-57. PubMed ID: 21796150
[TBL] [Abstract][Full Text] [Related]
8. Axl contributes to efficient migration and invasion of melanoma cells.
Shao H; Teramae D; Wells A
PLoS One; 2023; 18(3):e0283749. PubMed ID: 36989239
[TBL] [Abstract][Full Text] [Related]
9. The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function.
Varone A; Amoruso C; Monti M; Patheja M; Greco A; Auletta L; Zannetti A; Corda D
Cell Commun Signal; 2021 Jun; 19(1):64. PubMed ID: 34088320
[TBL] [Abstract][Full Text] [Related]
10. The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma.
Iizuka S; Abdullah C; Buschman MD; Diaz B; Courtneidge SA
Oncotarget; 2016 Nov; 7(48):78473-78486. PubMed ID: 27802184
[TBL] [Abstract][Full Text] [Related]
11. Significance of kinase activity in the dynamic invadosome.
Foxall E; Pipili A; Jones GE; Wells CM
Eur J Cell Biol; 2016 Nov; 95(11):483-492. PubMed ID: 27465307
[TBL] [Abstract][Full Text] [Related]
12. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.
Wang Y; Ou Z; Sun Y; Yeh S; Wang X; Long J; Chang C
Oncogene; 2017 Mar; 36(12):1644-1654. PubMed ID: 27869170
[TBL] [Abstract][Full Text] [Related]
14. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.
Rankin EB; Fuh KC; Castellini L; Viswanathan K; Finger EC; Diep AN; LaGory EL; Kariolis MS; Chan A; Lindgren D; Axelson H; Miao YR; Krieg AJ; Giaccia AJ
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13373-8. PubMed ID: 25187556
[TBL] [Abstract][Full Text] [Related]
15. Axl of evil?
Aplin AE
J Invest Dermatol; 2011 Dec; 131(12):2343-5. PubMed ID: 22071539
[TBL] [Abstract][Full Text] [Related]
16. BRN2 and MITF together impact AXL expression in melanoma.
Simmons JL; Neuendorf HM; Boyle GM
Exp Dermatol; 2022 Jan; 31(1):89-93. PubMed ID: 33119145
[TBL] [Abstract][Full Text] [Related]
17. Invadopodia, a Kingdom of Non-Receptor Tyrosine Kinases.
Saha T; Gil-Henn H
Cells; 2021 Aug; 10(8):. PubMed ID: 34440806
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.
Song X; Akasaka H; Wang H; Abbasgholizadeh R; Shin JH; Zang F; Chen J; Logsdon CD; Maitra A; Bean AJ; Wang H
J Biol Chem; 2020 Feb; 295(8):2348-2358. PubMed ID: 31959629
[TBL] [Abstract][Full Text] [Related]
19. Signaling inputs to invadopodia and podosomes.
Hoshino D; Branch KM; Weaver AM
J Cell Sci; 2013 Jul; 126(Pt 14):2979-89. PubMed ID: 23843616
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation.
Venghateri JB; Dassa B; Morgenstern D; Shreberk-Shaked M; Oren M; Geiger B
Cell Death Dis; 2023 Apr; 14(4):290. PubMed ID: 37185904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
